Back to Journals » International Journal of General Medicine » Volume 13

Prevalence and Predictors of Thyroid Dysfunction Among Type 2 Diabetic Patients: A Case–Control Study

Authors Khassawneh AH, Al-Mistarehi AH, Zein Alaabdin AM, Khasawneh L, AlQuran TM, Kheirallah KA, Saadeh NA, Beni yonis O, Shawkat M, Obeidat N

Received 25 July 2020

Accepted for publication 14 September 2020

Published 12 October 2020 Volume 2020:13 Pages 803—816

DOI https://doi.org/10.2147/IJGM.S273900

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Scott Fraser


Adi H Khassawneh,1 Abdel-Hameed Al-Mistarehi,1 Anas M Zein Alaabdin,1 Laith Khasawneh,2 Thekraiat M AlQuran,1 Khalid A Kheirallah,1 Nesreen A Saadeh,3 Othman Beni yonis,1 Mohamid Shawkat,1 Nail Obeidat4

1Department of Public Health and Family Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan; 2Department of Surgery, Faculty of Medicine, The Hashemite University, Zarqa, Jordan; 3Department of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan; 4Department of Obstetrics and Gynecology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

Correspondence: Adi H Khassawneh Department of Public Health and Family Medicine, Faculty of Medicine
Jordan University of Science and Technology, P.O.Box 3030, Irbid 21110, Jordan
Tel +962799199565
Email ohkhasawneh@just.edu.jo

Background: Type 2 diabetes mellitus (T2DM) and thyroid disorders are common endocrine disorders. This case–control study aims to determine the prevalence and predictors of thyroid disorders in T2DM patients.
Methods: A total of 998 T2DM patients attending a tertiary hospital were included and underwent investigations for thyroid function: thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3); and glycated hemoglobin (HbA1c). They were compared with 343 non-diabetic subjects as controls.
Results: A total of 1341 participants were included in the study. The mean age ± SD was 60.14 ± 12.21, and 47.9% were females. Among T2DM patients, 140 (14%) were known to have thyroid disorders; and as a direct result of screening, 126 (12.6%) new cases of thyroid disorder were diagnosed. Thus, the overall prevalence of thyroid disorders was found to be 26.7% in T2DM patients which significantly higher than the controls (13.7%), (p˂0.001). Subclinical hypothyroidism was the most common one. Using logistic regression, after adjusting for age, gender, obesity, smoking, anemia, presence of goiter, disease duration, and poorly controlled, the risk factors for thyroid dysfunction among T2DM patients were an age of ≥ 50 years with an adjusted OR of 3.895 (95% CI 2.151– 7.052, p< 0.001); female gender (OR 1.757, 95% CI 1.123– 2.747, p=0.013); goiter (OR 2.904, 95% CI 1.118– 7.547, p=0.029), and HbA1c> 7% (OR 2.553, 95% CI 1.472– 4.429, p=0.001). However, there were no significant associations between thyroid disorders and complications or duration of diabetes (p> 0.050).
Conclusion: A high prevalence of thyroid disorders was reported in T2DM patients. Therefore, we suggest that diabetic patients should be routinely screened for thyroid dysfunction. Old age, female gender, goiter, and poorly controlled diabetes found to be risk factors for thyroid dysfunction among T2DM patients. Consequently, appropriate management and control of diabetes may lower the risk of thyroid dysfunction and vice versa.

Keywords: type 2 diabetes mellitus, DM, thyroid dysfunction, thyroid disorders, hypothyroidism, hyperthyroidism, poorly controlled diabetes

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]